Elsevier

Gastrointestinal Endoscopy

Volume 50, Issue 5, November 1999, Pages 667-671
Gastrointestinal Endoscopy

Endoscopic and histologic healing of Crohn's (ileo-) colitis with azathioprine

https://doi.org/10.1016/S0016-5107(99)80017-0Get rights and content

Background: The correlation between disease activity and endoscopic findings in Crohn's disease is poor. Corticosteroids induce symptom relief without consistent improvement of endoscopic lesions. Our aim was to examine the effect of azathioprine therapy on healing of inflammatory lesions in patients with severe Crohn's disease.

Methods: The study included 20 consecutive patients with Crohn's colitis or ileocolitis in clinical remission while taking azathioprine for at least 9 months and no corticosteroids for at least 3 months who had had an ileocolonoscopy less than 1 year, before the start of azathioprine. All 20 patients underwent a new ileocolonoscopy with biopsies.

Results: The duration of azathioprine therapy was 24.4±13.7 months. In the colon, we observed complete healing in 14 of 20 patients (70%), near-complete healing in 2 of 20 (10%), partial healing in 3 of 20 (15%), and no healing in 1 of 20 (5%). In the ileum complete healing was seen in 7 of 13 (54%) patients with ileitis, near-complete healing in 2 of 13 (15%), partial healing in 1 of 13 (8%), and no healing in 2 of 13 (15%); the ileum was not reached in 1 patient. Histologic examination revealed disappearance of the inflammatory infiltrate, with a certain degree of architectural disturbance remaining.

Conclusions: Successful azathioprine therapy is accompanied by mucosal healing and disappearance of the inflammatory infiltrate.

Cited by (221)

  • Histologic evaluation of disease activity in inflammatory bowel disease

    2020, Atlas of Endoscopy Imaging in Inflammatory Bowel Disease
  • Does Azathioprine induce endoscopic and histologic healing in pediatric inflammatory bowel disease? A prospective, observational study

    2018, Digestive and Liver Disease
    Citation Excerpt :

    In the first paper, 15 CD patients with post-operative recurrence of ileitis, treated with AZA, reached EH in approximately 40% of cases, after a median time of 18 months [26]. In the 2nd study, 54% of CD patients showed healing of the mucosal lesions located in the ileum and 70% healing of the colonic lesions, after a median time of treatment of 2 years with AZA [27]. More recently, Mantzaris et al., randomized 77 patients with steroid-dependent CD to receive either budesonide or AZA as maintenance treatment for 1 year.

  • Mercaptopurine therapy

    2023, Pediatric Inflammatory Bowel Disease
View all citing articles on Scopus
View full text